Weisi Liu
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Galectins and Cancer Biology
Papers in
-
- Glycosylation and Glycoproteins Research 4
- Epigenetics and DNA Methylation 3
- Renal and related cancers 2
-
- Renal cell carcinoma treatment 10
- Co-authors
- Jiejie Xu (25 shared papers)Weijuan Zhang (18 shared papers)Haiou Liu (17 shared papers)Yidong Liu (16 shared papers)Jianxin Gu (9 shared papers)Qiang Fu (10 shared papers)Deng Pan (6 shared papers)Le Xu (9 shared papers)
- Journals
- Urologic Oncology Seminars and Original Investigations (4 papers)Tumor Biology (3 papers)Journal of Biological Chemistry (3 papers)Frontiers in Public Health (2 papers)Oncotarget (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Weisi Liu
33 papers receiving 656 citations
Peers
Comparison fields: 5 of 73
- Cancer Research 160
- Immunology 150
- Oncology 140
- Molecular Biology 360
- Hepatology 26
Countries citing papers authored by Weisi Liu
This map shows the geographic impact of Weisi Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weisi Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weisi Liu more than expected).
Fields of papers citing papers by Weisi Liu
This network shows the impact of papers produced by Weisi Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weisi Liu. The network helps show where Weisi Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Weisi Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 102 | |
| 2 | 2014 | 86 | |
| 3 | 2013 | 39 | |
| 4 | 2017 | 33 | |
| 5 | 2013 | 32 | |
| 6 | 2015 | 32 | |
| 7 | 2015 | 30 | |
| 8 | 2015 | 23 | |
| 9 | 2013 | 23 | |
| 10 | 2022 | 23 | |
| 11 | 2017 | 22 | |
| 12 | 2016 | 22 | |
| 13 | 2015 | 20 | |
| 14 | 2021 | 18 | |
| 15 | 2015 | 17 | |
| 16 | 2014 | 15 | |
| 17 | 2014 | 14 | |
| 18 | 2015 | 14 | |
| 19 | 2014 | 14 | |
| 20 | 2014 | 13 |
About Weisi Liu
Weisi Liu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Cancer Research and Immunology, having authored 33 papers that have together received 663 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (10 papers), Glycosylation and Glycoproteins Research (4 papers), Galectins and Cancer Biology (4 papers), Epigenetics and DNA Methylation (3 papers), MicroRNA in disease regulation (3 papers), Cancer Genomics and Diagnostics (2 papers), Renal and related cancers (2 papers) and Bladder and Urothelial Cancer Treatments (2 papers). The work is most often cited by research in Cancer Research (160 citations), Immunology (150 citations), Oncology (140 citations), Molecular Biology (360 citations) and Hepatology (26 citations). Weisi Liu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Jiejie Xu, Weijuan Zhang, Haiou Liu, Yidong Liu, Jianxin Gu, Qiang Fu, Deng Pan, Le Xu, Qian Wu and Yidong Liu. Their work appears in journals such as Urologic Oncology Seminars and Original Investigations, Tumor Biology, Journal of Biological Chemistry, Frontiers in Public Health and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.